Recent progress in the treatment of Cushing's disease

被引:1
作者
Bertagna, Xavier [1 ]
Guignat, Laurence [1 ]
机构
[1] Univ Paris 05, Fac Med Paris Descartes, Hop Cochin, Serv Malad Endocriniennes & Metabol,Ctr Reference, F-75014 Paris, France
关键词
LONG-TERM TREATMENT; THERAPEUTIC TARGET; ADRENALECTOMY; ETOMIDATE; HYPERCORTISOLEMIA; ROSIGLITAZONE; MIFEPRISTONE; MANAGEMENT; SURGERY;
D O I
10.1016/j.ando.2012.03.036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transsphenoidal surgery, possibly through the endoscopic approach, remains the first line treatment. Opposing cortisol action with mifepristone proved efficacious in some individual cases but but with major monitoring difficulties. Combined treatment with three anticortisolic drugs (metyrapone, ketokonazole, O,p'DDD) is particularly attractive in severe cases. The Nelson's syndrome has been revisited, and the corticotroph tumor progression should rather be cautiously assessed after bilateral adrenalectomy. Two molecules potentially act directly to suppress the ACTH secretion by the corticotroph adenoma: agonists of the D2 Dopamine receptor and of the somatostatin receptor type 5. Their efficacy remains modest (20 to 30% of the patients actually normalize urinary cortisol). Pituitary radiotherapy can be efficiently performed by stereotaxic approach. (C) 2012 Published by Elsevier Masson SAS.
引用
收藏
页码:107 / 110
页数:4
相关论文
共 43 条
[1]   Effects of chronic administration of PPAR-γ ligand rosiglitazone in Cushing's disease [J].
Ambrosi, B ;
Dall'Asta, C ;
Cannavò, S ;
Libé, R ;
Vigo, T ;
Epaminonda, P ;
Chiodini, L ;
Ferrero, S ;
Trimarchi, F ;
Arosio, M ;
Beck-Peccoz, P .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 151 (02) :173-178
[2]   Corticotroph tumor progression after adrenalectomy in Cushing's disease:: A reappraisal of Nelson's syndrome [J].
Assie, Guillaume ;
Bahurel, Helene ;
Coste, Joel ;
Silvera, Stephane ;
Kujas, Michele ;
Dugue, Marie-Annick ;
Karray, Foued ;
Dousset, Bertrand ;
Bertherat, Jerome ;
Legmann, Paul ;
Bertagna, Xavier .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (01) :172-179
[3]   The Nelson's syndrome... revisited [J].
Assié G. ;
Bahurel H. ;
Bertherat J. ;
Kujas M. ;
Legmann P. ;
Bertagna X. .
Pituitary, 2004, 7 (4) :209-215
[4]  
Baudry C, 2011, AM END SOC M 2011 BO
[5]  
Bertagna X, 2011, PITUITARY, 3RD EDITION, P533, DOI 10.1016/B978-0-12-380926-1.10016-1
[6]   Cushing's disease [J].
Bertagna, Xavier ;
Guignat, Laurence ;
Groussin, Lionel ;
Bertherat, Jerome .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (05) :607-623
[7]   Treatment of severe psychosis due to ectopic Cushing's syndrome [J].
Bilgin, Y. M. ;
van der Wiel, H. E. ;
Fischer, H. R. A. ;
De Herder, W. W. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2007, 30 (09) :776-779
[8]   Treatment of adrenocorticotropin-dependent Cushing's syndrome: A consensus statement [J].
Biller, B. M. K. ;
Grossman, A. B. ;
Stewart, P. M. ;
Melmed, S. ;
Bertagna, X. ;
Bertherat, J. ;
Buchfelder, M. ;
Colao, A. ;
Hermus, A. R. ;
Hofland, L. J. ;
Klibanski, A. ;
Lacroix, A. ;
Lindsay, J. R. ;
Newell-Price, J. ;
Nieman, L. K. ;
Petersenn, S. ;
Sonino, N. ;
Stalla, G. K. ;
Swearingen, B. ;
Vance, M. L. ;
Wass, J. A. H. ;
Boscaro, M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (07) :2454-2462
[9]   Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome [J].
Boscaro, M ;
Sonino, N ;
Scarda, A ;
Barzon, L ;
Fallo, F ;
Sartori, MT ;
Patrassi, GM ;
Girolami, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) :3662-3666
[10]   Treatment of Pituitary-Dependent Cushing's Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial [J].
Boscaro, M. ;
Ludlam, W. H. ;
Atkinson, B. ;
Glusman, J. E. ;
Petersenn, S. ;
Reincke, M. ;
Snyder, P. ;
Tabarin, A. ;
Biller, B. M. K. ;
Findling, J. ;
Melmed, S. ;
Darby, C. H. ;
Hu, K. ;
Wang, Y. ;
Freda, P. U. ;
Grossman, A. B. ;
Frohman, L. A. ;
Bertherat, J. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (01) :115-122